Theresa Micknick
Medical · Carbondale, PANPI 1164774261
Payments from drug & device makers
Across 659 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$1K
- GSK$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$819
- Lilly USA, LLC$727
- Amgen$603
- plus $3K from 24 others
What the payments were for
- Food & beverage$9,79998%
- Education$1792%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 146 | $1,974 |
| AstraZeneca(2 entities) | 57 | $1,363 |
| GSK | 52 | $1,030 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 98 | $819 |
| Lilly USA, LLC | 59 | $727 |
| Amgen | 24 | $603 |
| AbbVie | 40 | $567 |
| Pfizer | 44 | $527 |
| Boehringer Ingelheim | 23 | $434 |
| Lundbeck LLC | 26 | $377 |
| Otsuka America Pharmaceutical, Inc. | 13 | $248 |
| Merck | 10 | $141 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $136 |
| Astellas Pharma US Inc | 5 | $133 |
| Biohaven Pharmaceuticals, Inc. | 10 | $126 |
| Bayer | 1 | $122 |
| Sanofi-aventis U.S. LLC | 7 | $114 |
| Abbott | 7 | $102 |
| Avanir Pharmaceuticals, Inc. | 5 | $73 |
| Exact Sciences | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 6 | $53 |
| E.r. Squibb & Sons, L.L.C. | 4 | $53 |
| Novartis | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Verona Pharma, Inc. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $18 |
| Almatica Pharma LLC | 1 | $16 |
| Radius Health, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,978 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 180 | $231,395 |
| JardianceEmpagliflozin | 111 | $112,704 |
| EliquisApixaban | 70 | $66,243 |
| FarxigaDapagliflozin Propanediol | 44 | $49,601 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 44 | $39,458 |
| MyrbetriqMirabegron | 32 | $27,122 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 35 | $23,356 |
| XareltoRivaroxaban | 18 | $21,964 |
| MounjaroTirzepatide | 20 | $20,480 |
| Breo ElliptaFluticasone/Vilanterol | 38 | $17,313 |
| JanumetSitagliptin Phos/Metformin Hcl | 17 | $15,855 |
| Repatha SureclickEvolocumab | 25 | $13,658 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 30 | $9,353 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $6,601 |
| JanuviaSitagliptin Phosphate | 12 | $6,383 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,974 | $231,395180 claims |
| Boehringer IngelheimJardiance | $434 | $112,704111 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arexvy | $1,030 | $89,481147 claims |
| PfizerEliquis | $527 | $66,24370 claims |
| AstraZenecaFarxiga | $1,363 | $49,60144 claims |
| Astellas Pharma US IncMyrbetriq | $133 | $27,12232 claims |
| MerckJanumet, Januvia | $141 | $22,23829 claims |
| Lilly USA, LLCMounjaro | $727 | $20,48020 claims |
| AbbVieSynthroid, Armour Thyroid | $567 | $3,03847 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Carbondale
- Jacqueline KernaghanSpringfield$427K
- Drew SodaNew Hope$220K
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Cory DavidsonErie$119K
- Shelley SassamanTamaqua$90K
- Meghan HoffnerBethlehem$86K
- Thomas IacovoniDanville$72K
- Scott CoxWynnewood$66K
- Sarah SmithPhiladelphia$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.